Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Ocean Biomedical, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 34 | 35 | +1 |
| Shares | 9.86M | 10.2M | +315.0K (+3.2%) |
| Value | $99.4M | $102.9M | +$3.51M (+3.5%) |
New holders (4)
Institutions that held Ocean Biomedical, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vivaldi Asset Management, LLC | 568,574 | $5.75M | 0.40% |
| Yakira Capital Management, Inc. | 400,000 | $4.04M | 0.64% |
| Kim, LLC | 135,500 | $1.38M | 0.07% |
| P Schoenfeld Asset Management LP | 80,263 | $811.0K | 0.05% |
Sold out (3)
Institutions that held Ocean Biomedical, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Beryl Capital Management LLC | 673,674 | $6.79M |
| Spring Creek Capital LLC | 135,500 | $1.37M |
| Whitebox Advisors LLC | 102,800 | $1.04M |